Medicine and Dentistry
Patient
100%
Clindamycin
40%
Therapeutic Procedure
40%
Chemotherapeutic Agent
40%
Clostridium Difficile Infection
40%
Infection
40%
Drug
40%
Moraxella
40%
Lupus Nephritis
40%
Staphylococcus aureus
33%
Pseudomembranous Colitis
30%
Cytomegalovirus
30%
Beta Hemolytic Streptococcus
26%
Erythromycin
26%
Zygomycosis
20%
Bacteremia
20%
Eye Infection
20%
Fungus Ball
20%
Antimicrobial Therapy
20%
Association
20%
Knee Arthritis
20%
Moraxellaceae Infection
20%
Septic Arthritis
20%
Daptomycin
13%
Clinical Trial
13%
Linezolid
13%
Soft Tissue Infection
13%
Meticillin
13%
Staphylococcus Aureus
13%
Skin
13%
Mortality
11%
Recurrent Disease
10%
Peptoclostridium difficile
10%
Complication
10%
Kidney Infection
10%
Tissues
10%
Combination Therapy
10%
Posaconazole
10%
Renal Failure
10%
Colitis
10%
Etiology
10%
Amphotericin B Lipid Complex
10%
Bezoar
10%
Diagnosis
10%
Quinolone Derivative
7%
Bactericidal Activity
6%
Motivation
6%
Oritavancin
6%
Tigecycline
6%
Dalbavancin
6%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
40%
Clindamycin
40%
Clostridium Difficile Infection
40%
Infection
30%
Cytomegalovirus
30%
Beta Hemolytic Streptococcus
26%
Erythromycin
26%
Case Report
20%
Staphylococcus Aureus
13%
Meticillin
13%
Linezolid
13%
Daptomycin
13%
Soft Tissue Infection
13%
Mortality
11%
Complication
10%
Peptoclostridium difficile
10%
Etiology
10%
Colitis
10%
Quinolone Derivative
7%
Tigecycline
6%
Gram Positive Bacterium
6%
Minocycline
6%
Oritavancin
6%
Glycopeptide
6%
Dalbavancin
6%
Pneumonia
6%
Dalfopristin Plus Quinupristin
6%
Infectious Agent
6%
Nursing and Health Professions
Outpatient
40%
Fungus Ball
20%
Zygomycosis
20%
Antimicrobial Therapy
20%
Patient
15%
Combination Therapy
10%
Infection
10%
Posaconazole
10%
Amphotericin B Lipid Complex
10%
Diagnosis
10%
Kidney Failure
10%
Recurrent Disease
10%
Kidney Infection
10%
Bezoar
10%
Patient with Substance Abuse
5%
Inpatient
5%
